ARGUMENTS AGAINST THE INEQUITABLE DISTRIBUTION OF VACCINES USING THE ACCESS AND BENEFIT SHARING TRANSACTION

Abstract Access and benefit sharing (ABS) is a transactional mechanism designed to allow countries trade access their sovereign genetic resources for monetary non-monetary benefits, with the ultimate goal of channelling those benefits into sustainable development environmental conservation. Arguments about how pathogens are not sort world ought conserve eventually gave way recognition that indeed under Convention on Biological Diversity its Nagoya Protocol, ABS transaction may be an effective deliver scarce vaccines developing nations as received in exchange shared pathogen samples. This article argues categorising given samples creates opposing incentives providers users virus undermines human right health because it makes commodity bought. The provision global research commons fair equitable distribution medicines should two parallel public goods pursued goals themselves. We conclude linking these through reassessed.